Can psychedelics have a role in psychiatry once again?
The British Journal of Psychiatry June 1, 2005 DOI: 10.1192/bjp.186.6.457 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | LSD MDMA Mescaline Psilocybin |
| Keywords | Hallucinogen Phenethylamine |
| Citations | 97 |
| Key points | Psychedelic drugs occur in abundance in nature and have a long history of human use. |
Abstract
Psychedelic or hallucinogenic drugs such as lysergic acid diethylamide (LSD), 3, 4, 5-trimethoxy-β-phenethylamine (mescaline), psilocybin, 3, 4-methylenedioxymethamph-etamine (MDMA), N, N-dimethyltrypta-mine (DMT) and their relations occur in abundance throughout the natural world, and have been used by humankind for thousands of years.
Citations in the library
Cited by 60
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin – Summary of knowledge and new perspectives European Neuropsychopharmacology December 17, 2013
- The globalization of ayahuasca: Harm reduction or benefit maximization? International Journal of Drug Policy December 5, 2006
- Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities The International Journal of Neuropsychopharmacology May 17, 2017
and 55 more in the library